National Health Investors, Inc. (NHI) Guidance & Earnings Results

On 2026-05-04 National Health Investors, Inc. lowered guidance: "FY2026 NAREIT FFO per diluted share lowered to $4.74-$4.79 from $4.94-$4.99; Normalized FFO per diluted share lowered to $4.74-$4.79 from $4.94-$4.99; Normalized FAD lowered to $240.6-$243.7M from…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

NHINational Health Investors, Inc.Follow NHI — free

REIT - Healthcare Facilities · Real Estate

—

Price chart with a free account

Market cap: 3.3B
P/E TTM: 19.4
Dividend yield: 5.5%
52-week: —
Next earnings: 9 Nov, in 16 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
4 May 26	Lowered	FY2026 NAREIT FFO per diluted share lowered to $4.74-$4.79 from $4.94-$4.99; Normalized FFO per diluted share lowered to $4.74-$4.79 from $4.94-$4.99; Normalized FAD lowered to $240.6-$243.7M from $248.9-$251.4M · full year
26 Feb 26	Raised	2026 Normalized FFO guidance $4.94-$4.99 vs 2025 actual $4.91; Normalized FAD $248.9M-$251.4M vs 2025 $232.1M · full year
6 Nov 25	Raised	FY2025 Normalized FFO guidance raised to $4.88-$4.91 from $4.78-$4.82; Normalized FAD to $231.7M-$233.5M from $227.9M-$229.8M · full year
6 Aug 25	Raised	FY25 Normalized FFO per share raised to $4.78-$4.82 from $4.68-$4.73; FY25 Normalized FAD raised to $227.9M-$229.8M from $223.8M-$226.4M; FY25 NAREIT FFO per share lowered to $4.46-$4.50 from $4.64-$4.70; Same-store SHOP NOI growth 13%-16% · full year

National Health Investors, Inc. — questions

What guidance did National Health Investors, Inc. give?: On 2026-05-04: "FY2026 NAREIT FFO per diluted share lowered to $4.74-$4.79 from $4.94-$4.99; Normalized FFO per diluted share lowered to $4.74-$4.79 from $4.94-$4.99; Normalized FAD lowered to $240.6-$243.7M from $248.9-$251.4M"
When does National Health Investors, Inc. report earnings?: National Health Investors, Inc.'s next earnings report is expected on 2026-11-09.

Every figure on this page comes from National Health Investors, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.